The timeline is laid out in a new MHRA strategy document that aims to update and reform the regulation of AI used for medical purposes, part of an ongoing update to its framework for medical devices.

The UK’s life sciences sector is missing out on £15bn annually due to declining global competitiveness, falling exports and ...

Backers of Reform UK are significantly more likely than the general public to not have taken Covid vaccines, a poll has found ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) isn't sufficiently funded to meet its obligations, according to a new report commissioned by a pharma trade organisation.